General Gastro News Articles

Gastro

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Weiss B et al. – Response to treatment with systemic steroids, AZA/6–MP and infliximab are not related to NOD2/CARD15 mutations, age of diagnosis and disease behavior. Patients with colonic disease have higher rates of steroid dependency.

Related Articles

A Case-Control Study on Risk Factors of Osteoporosis in Patients with Crohn's Disease
Archives of Iranian Medicine, 11/13/09    Relevance Score: 69%

Gastrointestinal stromal tumor causing small bowel intussusception in a patient with Crohn's disease
World Journal of Gastroenterology, 11/13/09    Relevance Score: 68%

Pathogenesis of inflammatory bowel disease (IBD)
The Internet Journal of Gastroenterology, 11/13/09    Relevance Score: 68%

Bowel Disease Treatment May Raise Skin Cancer Risk
MedLinePlus, 10/28/09    Relevance Score: 68%

Methotrexate for maintenance of remission in Crohn's disease
Cochrane Reviews, 10/27/09    Relevance Score: 68%

Today in Inflammatory Bowel Dz...keeping you current

The role of appendicectomy in the subsequent development of inflammatory bowel disease: a UK-based study
International Journal of Colorectal Disease, 12/18/09

Delayed Colonic Perforation after ESD in a Patient with Ulcerative Colitis: A Case Report and Review of the Literature
The Internet Journal of Gastroenterology, 12/18/09

Clinical outcome of newly diagnosed Crohns disease: a comparative, retrospective study before and after infliximab availability
Alimentary Pharmacology and Therapeutics, 12/17/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address